소아 알레르기 질환의 임상역학적 연구 설계 = REVIEW : Clinicoepidemiological research designs in childhood allergic diseases

다국어 초록 (Multilingual Abstract)

Clinical epidemiology is defined as a method for investigating the distribution and determinants of diseases and for applying this knowledge in their prevention, and simply means application of epidemiological methods for medical research. In evidence-based medicine, randomized controlled trials (RCT) are the gold standard for assessing efficacy and safety of the intervention, while it is commonly impractical because of many limitations, such as ethical/legal problems and weak external-validity. High internal-validity of RCT permits to assess the direct efficacy of intervention without interference with bias and confounder; however, it has less generalizability or applicability to the real-life practice. Evidence-based practical guidelines are developed for patient management and decision making in real-life practice; paradoxically, the evidence of the guidelines does not come from real life, but from strict trial life. To overcome these limitations, pragmatic clinical trials for assessing the effectiveness of intervention in real-life practice or high-quality observational studies would be the best alternatives or could add more strong evidence. This article provides an overview of clinicoepidemiological research designs in the field of childhood allergic diseases and their strength/weakness. (Allergy Asthma Respir Dis 2016;4:91-99)

참고문헌 (Reference)

1 Castro-Rodriguez JA, "Wheezing and Asthma in childhood: an epidemiology approach" 36 : 280-290, 2008

2 Röhrig B, "Types of study in medical research: part 3 of a series on evaluation of scientific publications" 106 : 262-268, 2009

3 Dorais M, "Treatment persistence with leukotriene receptor antagonists and inhaled corticosteroids" 42 : 385-393, 2005

4 Brass EP, "The gap between clinical trials and clinical practice: the use of pragmatic clinical trials to inform regulatory decision making" 87 : 351-355, 2010

5 Proctor RN, "The anti-tobacco campaign of the Nazis: a little known aspect of public health in Germany, 1933-45" 313 : 1450-1453, 1996

6 Woodcock A, "The Salford Lung Study protocol: a pragmatic, randomised phase III real-world effectiveness trial in asthma" 15 : 160-, 2015

7 Yang HJ, "The Cohort for Childhood Origin of Asthma and allergic diseases (COCOA) study: design, rationale and methods" 14 : 109-, 2014

8 "STREPTOMYCIN treatment of pulmonary tuberculosis" 2 : 769-782, 1948

9 Beasley R, "Risk factors for asthma: is prevention possible?" 386 : 1075-1085, 2015

10 Caminati M, "Respiratory allergies in childhood: Recent advances and future challenges" 26 : 702-710, 2015

11 Rivas-Ruiz F, "Research designs in clinical epidemiology" 40 : 117-124, 2012

12 Price D, "Real-world research and its importance in respiratory medicine" 11 : 26-38, 2015

13 Concato J, "Randomized, controlled trials, observational studies, and the hierarchy of research designs" 342 : 1887-1892, 2000

14 Magnus MC, "Prospective study of maternal alcohol intake during pregnancy or lactation and risk of childhood asthma: the Norwegian Mother and Child Cohort Study" 38 : 1002-1011, 2014

15 Lurie JD, "Pros and cons of pragmatic clinical trials" 2 : 53-58, 2013

16 Halterman JS, "Prompting asthma intervention in Rochester-uniting parents and providers (PAIR-UP): a randomized trial" 168 : E141983-, 2014

17 Sordillo JE, "Prenatal and infant exposure to acetaminophen and ibuprofen and the risk for wheeze and asthma in children" 135 : 441-448, 2015

18 Yang HJ, "Population-based study on association between birth weight and risk of asthma: a propensity score approach" 110 : 18-23, 2013

19 Cheelo M, "Paracetamol exposure in pregnancy and early childhood and development of childhood asthma: a systematic review and meta-analysis" 100 : 81-89, 2015

20 Singh M, "Paracetamol as a risk factor for allergic disorders" 373 : 119-, 2009

21 Lawrence J, "Paracetamol as a risk factor for allergic disorders" 373 : 119-, 2009

22 Bateman ED, "Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone" 69 : 312-319, 2014

23 DiPietro NA, "Methods in epidemiology: observational study designs" 30 : 973-984, 2010

24 Price D, "Leukotriene antagonists as first-line or add-on asthma-controller therapy" 364 : 1695-1707, 2011

25 Roche N, "Integrating real-life studies in the global therapeutic research framework" 1 : E29-E30, 2013

26 Yang HJ, "Inhalation toxicity of humidifier disinfectants as a risk factor of children's interstitial lung disease in Korea: a case-control study" 8 : E64430-, 2013

27 Iwanaga T, "Importance of clinical epidemiology research in studies on respiratory diseases" 51 : 217-223, 2013

28 Moore WC, "Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program" 181 : 315-323, 2010

29 Kim KW, "Humidifier disinfectant-associated children's interstitial lung disease" 189 : 48-56, 2014

30 Ortqvist AK, "Familial factors do not confound the association between birth weight and childhood asthma" 124 : E737-E743, 2009

31 Mosnaim G, "Factors associated with levels of adherence to inhaled corticosteroids in minority adolescents with asthma" 112 : 116-120, 2014

32 Travers J, "External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?" 62 : 219-223, 2007

33 Cai T, "Evaluating prognostic accuracy of biomarkers in nested case-control studies" 13 : 89-100, 2012

34 Newcomb DC, "Estrogen and progesterone decrease let-7f microRNA expression and increase IL-23/IL-23 receptor signaling and IL-17A production in patients with severe asthma" 136 : 1025-1034, 2015

35 Lynch SV, "Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children" 134 : 593-601, 2014

36 Been JV, "Effect of smoke-free legislation on perinatal and child health: a systematic review and meta-analysis" 383 : 1549-1560, 2014

37 Kramer MS, "Effect of prolonged and exclusive breast feeding on risk of allergy and asthma: cluster randomised trial" 335 : 815-, 2007

38 Kelly HW, "Effect of inhaled glucocorticoids in childhood on adult height" 367 : 904-912, 2012

39 Woodcock A, "Early life environmental control: effect on symptoms, sensitization, and lung function at age 3 years" 170 : 433-439, 2004

40 Rueter K, "Developing primary intervention strategies to prevent allergic disease" 15 : 40-, 2015

41 Krauskopf KA, "Depressive symptoms, low adherence, and poor asthma outcomes in the elderly" 50 : 260-266, 2013

42 Price D, "Current controversies and challenges in allergic rhinitis management" 11 : 1205-1217, 2015

43 Covar RA, "Contributions to the Understanding of Therapy and the Natural History of Childhood Asthma" 1 : 243-250, 2012

44 Campbell MK, "Consort 2010 statement: extension to cluster randomised trials" 345 : E5661-, 2012

45 Nath R, "Clinical epidemiology: what, why and how?" 43 : 83-87, 1995

46 Bousquet J, "Birth cohorts in asthma and allergic diseases: report of a NIAID/NHLBI/MeDALL joint workshop" 133 : 1535-1546, 2014

47 Beasley R, "Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6-7 years: analysis from Phase Three of the ISAAC programme" 372 : 1039-1048, 2008

48 Battaglia S, "Are asthmatics enrolled in randomized trials representative of real-life outpatients?" 89 : 383-389, 2015

49 Chauhan BF, "Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children" 5 : CD002314-, 2012

50 Osterberg L, "Adherence to medication" 353 : 487-497, 2005

51 Garbutt JM, "A cluster-randomized trial shows telephone peer coaching for parents reduces children's asthma morbidity" 135 : 1163-1170, 2015